Week 4 on tirz — bloodwork update

Four weeks in on tirzepatide weekly. Standard escalation (2.5mg → 5mg week 5). Fasting glucose down 12 points. Triglycerides down 28%. Weight down 4.2%.

GI side effects manageable. Nausea peaked at week 1, basically gone by week 3.

Baseline biomarkers were good but not exceptional. The metabolic response is in line with the SURMOUNT-1 average for early weeks.